rs111033590
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_213655.5(WNK1):c.3301C>T(p.Gln1101*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000684 in 1,461,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_213655.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary sensory and autonomic, type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
- pseudohypoaldosteronism type 2CInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- hereditary sensory and autonomic neuropathy type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| WNK1 | ENST00000340908.9 | c.3301C>T | p.Gln1101* | stop_gained | Exon 10 of 28 | 5 | NM_213655.5 | ENSP00000341292.5 | ||
| WNK1 | ENST00000315939.11 | c.2140-2493C>T | intron_variant | Intron 8 of 27 | 1 | NM_018979.4 | ENSP00000313059.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000201 AC: 5AN: 249232 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461688Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727130 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neuropathy, hereditary sensory and autonomic, type 2A Pathogenic:1Other:1
- -
French Canadian founder variants -
Inborn genetic diseases Pathogenic:1
The p.Q1101* pathogenic mutation (also known as c.3301C>T), located in coding exon 10 of the WNK1 gene, results from a C to T substitution at nucleotide position 3301. This changes the amino acid from a glutamine to a stop codon within coding exon 10. This alteration was detected in the homozygous state in an individual with hereditary sensory and autonomic neuropathy type II; however, clinical details were limited (Lafreniere RG et al. Am J Hum Genet, 2004 May;74:1064-73). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Pseudohypoaldosteronism type 2C;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln1101*) in the WNK1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in WNK1 are known to be pathogenic (PMID: 22910560). This variant is present in population databases (rs111033590, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with hereditary sensory and autonomic neuropathy (PMID: 15060842). This variant is also known as c.943C>T (p.Gln315*). ClinVar contains an entry for this variant (Variation ID: 5166). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at